Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 120

1.

Dietary Interventions for Gout and Effect on Cardiovascular Risk Factors: A Systematic Review.

Vedder D, Walrabenstein W, Heslinga M, de Vries R, Nurmohamed M, van Schaardenburg D, Gerritsen M.

Nutrients. 2019 Dec 4;11(12). pii: E2955. doi: 10.3390/nu11122955. Review.

2.

First Validation of the Full PROMIS Pain Interference and Pain Behavior Item Banks in Patients with Rheumatoid Arthritis.

Crins MHP, Terwee CB, Westhovens R, van Schaardenburg D, Smits N, Joly J, Verschueren P, Van der Elst K, Dekker J, Boers M, Roorda LD.

Arthritis Care Res (Hoboken). 2019 Sep 28. doi: 10.1002/acr.24077. [Epub ahead of print]

PMID:
31562795
3.

Adherence to Treat-to-Target Management in Rheumatoid Arthritis and Associated Factors: Data from the International RA BIODAM Cohort.

Sepriano A, Ramiro S, FitzGerald O, Østergaard M, Homik J, van der Heijde D, Elkayam O, Thorne C, Larché MJ, Ferraccioli G, Backhaus M, Burmester GR, Boire G, Combe B, Saraux A, Dougados M, Rossini M, Govoni M, Sinigaglia L, Cantagrel A, Barnabe C, Bingham CO 3rd, Tak PP, van Schaardenburg D, Hammer HB, Paschke J, Dadashova R, Hutchings E, Landewé R, Maksymowych WP.

J Rheumatol. 2019 Sep 15. pii: jrheum.190303. doi: 10.3899/jrheum.190303. [Epub ahead of print]

PMID:
31523049
4.

The International RA BIODAM Cohort for Validation of Soluble Biomarkers in Rheumatoid Arthritis: Cohort Description.

Maksymowych WP, FitzGerald O, Østergaard M, Homik J, van der Heijde D, Lambert RG, Elkayam O, Ramiro S, Thorne C, Larché MJ, Ferraccioli G, Backhaus M, Burmester GR, Boire G, Combe B, Saraux A, Dougados M, Rossini M, Govoni M, Sinigaglia L, Cantagrel A, Allaart R, Barnabe C, Bingham CO 3rd, Tak PP, van Schaardenburg D, Hammer HB, Paschke J, Dadashova R, Hutchings E, Sepriano A, Landewé R.

J Rheumatol. 2019 Sep 1. pii: jrheum.190302. doi: 10.3899/jrheum.190302. [Epub ahead of print]

PMID:
31474600
5.

Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol.

Al-Laith M, Jasenecova M, Abraham S, Bosworth A, Bruce IN, Buckley CD, Ciurtin C, D'Agostino MA, Emery P, Gaston H, Isaacs JD, Filer A, Fisher BA, Huizinga TWJ, Ho P, Jacklin C, Lempp H, McInnes IB, Pratt AG, Östor A, Raza K, Taylor PC, van Schaardenburg D, Shivapatham D, Wright AJ, Vasconcelos JC, Kelly J, Murphy C, Prevost AT, Cope AP.

Trials. 2019 Jul 15;20(1):429. doi: 10.1186/s13063-019-3403-7.

6.

Predicting Rheumatoid Arthritis in At-risk Individuals.

van Boheemen L, van Schaardenburg D.

Clin Ther. 2019 Jul;41(7):1286-1298. doi: 10.1016/j.clinthera.2019.04.017. Epub 2019 Jun 10.

PMID:
31196647
7.

Symptoms associated with inflammatory arthritis are common in the primary care population: results from the joint symptoms survey.

Hider SL, Muller S, Helliwell T, Prior JA, Scott I, Lawton SA, Zwierska I, van Schaardenburg D, van der Helm-van Mil A, Raza K, Mallen CD.

Rheumatology (Oxford). 2019 Nov 1;58(11):2009-2014. doi: 10.1093/rheumatology/kez184.

PMID:
31079150
8.

Pain, sleep and emotional well-being explain the lack of agreement between physician- and patient-perceived remission in early rheumatoid arthritis.

Turk SA, Rasch LA, van Schaardenburg D, Lems WF, Sanberg M, van Tuyl LHD, Ter Wee MM.

BMC Rheumatol. 2018 Jun 26;2:16. doi: 10.1186/s41927-018-0024-9. eCollection 2018.

9.

Change in cardiovascular risk after initiation of anti-rheumatic treatment in early rheumatoid arthritis.

Turk SA, Heslinga M, Twisk J, van der Lugt V, Lems WF, van Schaardenburg D, Nurmohamed MT.

Clin Exp Rheumatol. 2019 May-Jun;37(3):513. Epub 2019 Feb 15. No abstract available.

10.

The value of joint ultrasonography in predicting arthritis in seropositive patients with arthralgia: a prospective cohort study.

van Beers-Tas MH, Blanken AB, Nielen MMJ, Turkstra F, van der Laken CJ, Meursinge Reynders M, van Schaardenburg D.

Arthritis Res Ther. 2018 Dec 19;20(1):279. doi: 10.1186/s13075-018-1767-9.

11.

Depressive mood and low social support are not associated with arthritis development in patients with seropositive arthralgia, although they predict increased musculoskeletal symptoms.

Holla JFM, van Beers-Tas MH, van de Stadt LA, Landewé R, Twisk JWR, Dekker J, van Schaardenburg D.

RMD Open. 2018 Jun 27;4(1):e000653. doi: 10.1136/rmdopen-2018-000653. eCollection 2018.

12.

Multidisciplinary recommendations for diagnosis and treatment of foot problems in people with rheumatoid arthritis.

Tenten-Diepenmaat M, van der Leeden M, Vliet Vlieland TPM, Dekker J; RA Foot Expert Group.

J Foot Ankle Res. 2018 Jul 4;11:37. doi: 10.1186/s13047-018-0276-z. eCollection 2018.

13.

Initial validation and results of the Symptoms in Persons At Risk of Rheumatoid Arthritis (SPARRA) questionnaire: a EULAR project.

van Beers-Tas MH, Ter Wee MM, van Tuyl LH, Maat B, Hoogland W, Hensvold AH, Catrina AI, Mosor E, Stamm TA, Finckh A, Courvoisier DS, Filer A, Sahbudin I, Stack RJ, Raza K, van Schaardenburg D.

RMD Open. 2018 May 21;4(1):e000641. doi: 10.1136/rmdopen-2017-000641. eCollection 2018.

14.

An unfavorable body composition is common in early arthritis patients: A case control study.

Turk SA, van Schaardenburg D, Boers M, de Boer S, Fokker C, Lems WF, Nurmohamed MT.

PLoS One. 2018 Mar 22;13(3):e0193377. doi: 10.1371/journal.pone.0193377. eCollection 2018.

15.

Prevalence and validity of ACR/EULAR remission in four European early rheumatoid arthritis cohorts.

Britsemmer K, van Schaardenburg D, Boers M, De Cock D, Verschueren P, Radner H, Smolen JS, van Tuyl LHD.

Clin Exp Rheumatol. 2018 May-Jun;36(3):362-370. Epub 2018 Feb 26.

PMID:
29533752
16.

One-year Predictors of Presenteeism in Workers with Rheumatoid Arthritis: Disease-related Factors and Characteristics of General Health and Work.

Boot CRL, de Wind A, van Vilsteren M, van der Beek AJ, van Schaardenburg D, Anema JR.

J Rheumatol. 2018 Jun;45(6):766-770. doi: 10.3899/jrheum.170586. Epub 2018 Mar 1.

PMID:
29496893
17.

Rheumatoid factors do not preferentially bind to ACPA-IgG or IgG with altered galactosylation.

Falkenburg WJJ, Kempers AC, Dekkers G, Ooijevaar-de Heer P, Bentlage AEH, Vidarsson G, van Schaardenburg D, Toes REM, Scherer HU, Rispens T.

Rheumatology (Oxford). 2018 Apr 1;57(4):771. doi: 10.1093/rheumatology/key056. No abstract available.

PMID:
29481646
18.

Clinically relevant discrepancies between different rheumatoid factor assays.

Falkenburg WJJ, von Richthofen HJ, Koers J, Weykamp C, Schreurs MWJ, Bakker-Jonges LE, Haagen IA, Lems WF, Hamann D, van Schaardenburg D, Rispens T.

Clin Chem Lab Med. 2018 Sep 25;56(10):1749-1758. doi: 10.1515/cclm-2017-0988. No abstract available.

19.

Can an increase in autoantibody levels predict arthritis in arthralgia patients?

van Beers-Tas MH, Stuiver MM, de Koning MHMT, van de Stadt LA, Geskus RB, van Schaardenburg D.

Rheumatology (Oxford). 2018 May 1;57(5):932-934. doi: 10.1093/rheumatology/kex506. No abstract available.

PMID:
29401313
20.

Evolution of autoantibody responses in individuals at risk of rheumatoid arthritis.

Falkenburg WJJ, van Schaardenburg D.

Best Pract Res Clin Rheumatol. 2017 Feb;31(1):42-52. doi: 10.1016/j.berh.2017.07.005. Epub 2017 Aug 24. Review.

PMID:
29221597

Supplemental Content

Loading ...
Support Center